Beneficial and harmful outcomes of tocilizumab in severe COVID-19: A systematic review and meta-analysis.
Rubio-Rivas, Manuel 1; Forero, Carlos G. 2; Mora-Lujan, Jose Maria 1; Montero, Abelardo 1; Formiga, Francesc 1; Homs, Narcis A. 1; Alba-Albalate, Joan 1; Sanchez, Laura 1; Rello, Jordi 2,3,4; Corbella, Xavier 1,2
[Article] Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 41(11):884-906, November 2021.

(Format: HTML, PDF)